CANY
SWBI icon

Caxton Associates (New York)’s Smith & Wesson SWBI Stock Holding History

Caxton Associates (New York)’s Portfolio SWBI Stock Details SWBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-47,256
Closed -$613K – 668
2024
Q3 		$613K Buy
47,256
+28,289
+149% +$409K 0.02% 332
2024
Q2 		$272K Buy
+18,967
New +$311K 0.01% 409
2021
Q3 		– Sell
-14,941
Closed -$518K – 597
2021
Q2 		$518K Sell
14,941
-17,629
-54% -$369K 0.06% 166
2021
Q1 		$568K Buy
+32,570
New +$592K 0.05% 142
2020
Q3 		– Sell
-24,631
Closed -$407K – 509
2020
Q2 		$407K Buy
+24,631
New +$229K 0.04% 177

Other funds holding SWBI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Caxton Associates (New York)'s SWBI Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Smith & Wesson (SWBI) in Q4 2024, closing a stake of 47,256 shares — an estimated $613K sold.

Caxton Associates (New York) first reported a position in SWBI in Q2 2020 and held it in 5 quarters. The position peaked at $613K in Q3 2024. 182 funds tracked by Wall St. Rank hold SWBI as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Smith & Wesson position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 47,256 Smith & Wesson shares in Q4 2024, an estimated $613K.
  • Caxton Associates (New York) first reported a position in Smith & Wesson in Q2 2020 and held it in 5 quarters.
  • Caxton Associates (New York)'s Smith & Wesson position peaked at $613K in Q3 2024.
  • 182 funds tracked by Wall St. Rank held Smith & Wesson as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.